Table 2 |
|||||
|
Correlation between Jab1 expression and clinicopathological features of the estrogen receptor-alpha-negativea subset |
|||||
|
Jab1 |
|||||
|
Parameter |
Number |
Mean |
(Standard deviation) |
P value |
|
|
|
|||||
|
Gradeb |
|||||
|
Low |
12 |
91 |
(79) |
NS |
|
|
Intermediate |
70 |
61 |
(51) |
||
|
High |
72 |
49 |
(43) |
||
|
Size |
|||||
|
≤2 cm |
32 |
71 |
(63) |
NS |
|
|
>2 cm |
118 |
55 |
(50) |
||
|
Nodal status |
|||||
|
Negative |
55 |
43 |
(46) |
0.019 |
|
|
Positive |
87 |
64 |
(55) |
||
|
Progesterone receptorc |
|||||
|
Negative |
120 |
59 |
(51) |
NS |
|
|
Positive |
34 |
53 |
(57) |
||
|
EGFR |
|||||
|
Negative |
123 |
53 |
(50) |
0.019 |
|
|
Positive |
31 |
78 |
(57) |
||
|
S100A7 |
|||||
|
Negative |
59 |
48 |
(47) |
0.036 |
|
|
Positive |
95 |
64 |
(55) |
||
|
|
|||||
|
aEstrogen receptor-negative, <3 fmol/mg protein. bBased on Nottingham system. cProgesterone receptor-negative, <15 fmol/mg protein. EGFR, epidermal growth factor receptor; NS, not significant. |
|||||
|
Wang et al. Breast Cancer Research 2008 10:R51 doi:10.1186/bcr2105 |
|||||